Literature DB >> 1707039

Cerebrospinal fluid markers in neurological disorders.

A R Massaro1, G Scivoletto, P Tonali.   

Abstract

Cerebrospinal fluid (CSF) markers are a useful tool for determining disease progression or activity in some neurological disorders which need parameters both for evaluating treatments and investigating pathobiological evolution in research-oriented follow-up. A number of CSF proteins are reviewed with data on biological properties, analytical methods, clinical usefulness of: myelin basic protein, S-100 protein, glial fibrillary acidic protein, neural-cell adhesion molecule, neuron-specific enolase and others.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1707039     DOI： 10.1007/bf02337436

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN： 0392-0461


  54 in total

1.  Determination and characterization of neuron specific protein (NSP) associated enolase activity.

Authors:  P J Marangos; C Zomzely-Neurath; C York
Journal:  Biochem Biophys Res Commun       Date:  1976-02-23       Impact factor: 3.575

2.  A two-site immunoradiometric assay for the determination of alpha-albumin.

Authors:  M Noppe; A Lowenthal; D Karcher; J Gheuens
Journal:  J Immunol Methods       Date:  1979-05-10       Impact factor: 2.303

3.  Neuron-specific enolase as a marker of neuronal lesions during various comas in man.

Authors:  H Scarna; B Delafosse; R Steinberg; G Debilly; B Mandrand; A Keller; J F Pujol
Journal:  Neurochem Int       Date:  1982       Impact factor: 3.921

4.  CSF neopterin as marker of disease activity in multiple sclerosis.

Authors:  S Fredrikson; H Link; P Eneroth
Journal:  Acta Neurol Scand       Date:  1987-05       Impact factor: 3.209

5.  Radioimmunoassay of myelin basic protein in sodium sulfate.

Authors:  E D Day; O M Pitts
Journal:  Immunochemistry       Date:  1974-10

6.  A method for the electron microscopic study of cerebrospinal fluid sediment.

Authors:  R M Herndon; M Johnson
Journal:  J Neuropathol Exp Neurol       Date:  1970-04       Impact factor: 3.685

7.  Glial fibrillary acidic protein from normal and gliosed human brain. Demonstration of multiple related polypeptides.

Authors:  D Dahl; A Bignami
Journal:  Biochim Biophys Acta       Date:  1975-03-28

8.  Neuron-specific enolase is produced by neuroendocrine tumours.

Authors:  F J Tapia; J M Polak; A J Barbosa; S R Bloom; P J Marangos; C Dermody; A G Pearse
Journal:  Lancet       Date:  1981-04-11       Impact factor: 79.321

9.  Glial cells express N-CAM/D2-CAM-like polypeptides in vitro.

Authors:  M Noble; M Albrechtsen; C Møller; J Lyles; E Bock; C Goridis; M Watanabe; U Rutishauser
Journal:  Nature       Date:  1985 Aug 22-28       Impact factor: 49.962

10.  The S-100 antigen in cerebrospinal fluid as a possible index of cell injury in the nervous system.

Authors:  F Michetti; A Massaro; G Russo; G Rigon
Journal:  J Neurol Sci       Date:  1980-01       Impact factor: 3.181
View more
  4 in total

Review 1.  Primary diffuse leptomeningeal gliomatosis (PDLG): a neoplastic cause of chronic meningitis.

Authors:  P Y Dietrich; M S Aapro; A Rieder; G P Pizzolato
Journal:  J Neurooncol       Date:  1993-03       Impact factor: 4.130

Review 2.  Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

Authors:  M Andersson; J Alvarez-Cermeño; G Bernardi; I Cogato; P Fredman; J Frederiksen; S Fredrikson; P Gallo; L M Grimaldi; M Grønning
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

3.  Nerve growth factor (NGF) in cerebrospinal fluid (CSF) from patients with various neurological disorders.

Authors:  A R Massaro; C Soranzo; E Bigon; S Battiston; A Morandi; A Carnevale; L Callegaro
Journal:  Ital J Neurol Sci       Date:  1994-03

4.  Citicoline protects brain against closed head injury in rats through suppressing oxidative stress and calpain over-activation.

Authors:  Ke Qian; Yi Gu; Yumei Zhao; Zhenzong Li; Ming Sun
Journal:  Neurochem Res       Date:  2014-04-02       Impact factor: 3.996
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.